UNLOCKD Inc., a publicly traded holding company building a consumer health and wellness platform, has detailed the commercial rationale behind its proposed acquisition of Ancient Extracts Ltd, a British functional wellness business, following a binding letter of intent announced on November 3. The deal, if completed, would combine Ancient Extracts UK with its U.S. counterpart, Ancient Extracts USA, which UNLOCKD acquired in May 2026, to form an international wellness platform with substantial long-term growth potential. The announcement, first reported via NEWMEDIAWIRE, underscores UNLOCKD's strategy to scale through acquisitions of differentiated brands.
The significance of the proposed acquisition lies in Ancient Extracts UK's reported operating metrics, which management believes provide a solid foundation for growth. According to preliminary, unaudited information, the business generates approximately $920,000 in annualized revenue, with gross margins of about 75% and a recurring subscription base of roughly 540 active subscribers contributing nearly $240,000 in annualized subscription revenue. Other reported metrics include an average order value of $44, a customer lifetime revenue value of $200, a returning customer rate of 37%, a Shopify conversion rate of 3.3%, and a TikTok customer acquisition cost of $5. These figures suggest an efficient direct-to-consumer model with strong repeat purchasing, although the company notes that the business currently operates at approximately breakeven and that gross margins should not be interpreted as operating or net profit margins.
The strategic importance of the deal is further highlighted by the existing relationship between the two businesses. John P. Gorst, now CEO of UNLOCKD, previously established Ancient Extracts USA through VerdaGenix, LLC, and the underlying relationship with Ancient Extracts UK included a conditional contractual right to pursue a future acquisition. In July, Ancient Extracts UK Co-Founder Jamie Jarrett joined UNLOCKD's Board of Directors. Gorst emphasized that the company is not starting from scratch: “Ancient Extracts UK already has revenue, customers, subscriptions, products, and digital marketing infrastructure.” The combination is expected to leverage these capabilities, provide additional growth capital, and coordinate product development, customer acquisition, and distribution across the U.S. and UK, with potential expansion into additional European markets.
Management also pointed to the commercial scale demonstrated by established brands in the functional coffee and wellness categories, such as RYZE, Everyday Dose, and Four Sigmatic, whose annual revenues have been estimated at over $300 million, $100 million, and $50 million, respectively. While these third-party estimates are unverified and the companies differ materially from Ancient Extracts, UNLOCKD believes they illustrate the broader opportunity for Ancient Extracts' portfolio, which includes functional mushroom coffee, Himalayan shilajit, ceremonial matcha, and other wellness products. UNLOCKD's long-term objective is to build a consumer health and wellness company capable of generating $100 million or more in annual revenue, with Ancient Extracts potentially becoming a significant contributor.
However, the transaction remains subject to significant conditions, including qualifying financing, completion of an acceptable financial audit, satisfactory due diligence, required approvals, and execution of definitive agreements. There can be no assurance that the acquisition will be completed. Investors can find more information about UNLOCKD on its website at https://unlockdinc.com/, and details about Ancient Extracts UK are available at https://www.ancientextracts.co.uk/. The full release is available on www.newmediawire.com.


